Krush Media

A Kansas Senate Federal and State Affairs Committee held the first of two scheduled hearings this week on a medical cannabis legalization bill. Polling shows majority support for the reform in Kansas. Another hearing will take place in the panel tomorrow, with opponents set to testify. The legislation could potentially be taken up for a vote on Friday. In 2021, a medical cannabis bill passed the House but stalled out in the Senate. The committee also recently introduced a separate medical cannabis legalization bill. It’s not clear if or when members might take up that proposal.

Krush Media Group specializes in compliant cannabis advertising, accessing a direct, verified network.

*t

The FDA has released its finalized guidance on developing cannabis-based drugs, outlining the process and considerations for scientists regarding h**p and cannabis, as published in the Federal Register yesterday. Part of the reason for the guidance is the federal legalization of h**p in the 2018 Farm Bill, which makes the drug development protocol different for h**p than for ma*****na, which remains a Schedule I drug. The FDA made several non-binding recommendations for researchers, as the advice is “intended to address the legal definitions and regulatory controls related to cannabis, and to address certain questions raised about drugs containing cannabis.” As a general rule, cannabis containing no more than 0.3 percent THC by dry weight meets the federal definition of h**p and is not considered a controlled substance.

Krush Media Group specializes in compliant cannabis advertising, accessing a direct, verified network.

*t